We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-17.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10B
AUM Growth
-$4.54B
Cap. Flow
-$1.63B
Cap. Flow %
-16.3%
Top 10 Hldgs %
18.24%
Holding
2,308
New
654
Increased
395
Reduced
491
Closed
723

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$173M
2
EBAY icon
eBay
EBAY
+$149M
3
ZTS icon
Zoetis
ZTS
+$127M
4
TFX icon
Teleflex
TFX
+$108M
5
TMO icon
Thermo Fisher Scientific
TMO
+$98.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.96%
2 Consumer Discretionary 18.46%
3 Technology 13.47%
4 Financials 11.57%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBM
2251
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
-174,031
Closed -$3.37M
WPX
2252
DELISTED
WPX Energy, Inc.
WPX
-256,713
Closed -$3.53M
BSTC
2253
DELISTED
BioSpecifics Technologies Corp.
BSTC
-13,447
Closed -$766K
MYOK
2254
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-30,073
Closed -$2.19M
MR
2255
DELISTED
Montage Resources Corporation Common Stock
MR
-95,323
Closed -$757K
JCAP
2256
DELISTED
Jernigan Capital, Inc.
JCAP
-12,375
Closed -$237K
IMMU
2257
DELISTED
Immunomedics Inc
IMMU
-297,513
Closed -$6.29M
ONDK
2258
DELISTED
On Deck Capital, Inc.
ONDK
-96,201
Closed -$398K
PFNX
2259
DELISTED
Pfenex Inc.
PFNX
-12,262
Closed -$135K
MNTA
2260
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
-103,790
Closed -$2.05M
CCMP
2261
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-815
Closed -$118K
WUBA
2262
DELISTED
58.com Inc
WUBA
-6,062
Closed -$392K
BFYT
2263
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
-2,473
Closed -$48K
SBBX
2264
DELISTED
SB One Bancorp Common Stock
SBBX
-3,433
Closed -$86K
GCAP
2265
DELISTED
Gain Capital Holdings, Inc.
GCAP
-7,700
Closed -$30K
LM
2266
DELISTED
Legg Mason, Inc.
LM
-107,005
Closed -$3.84M
CVIA
2267
DELISTED
Covia Holdings Corporation Common Stock
CVIA
-39,547
Closed -$81K
AXE
2268
DELISTED
Anixter International Inc
AXE
-29,012
Closed -$2.67M
EQM
2269
DELISTED
EQM Midstream Partners, LP
EQM
-27,816
Closed -$832K
FTSI
2270
DELISTED
FTS International, Inc. Common Stock
FTSI
-3,224
Closed -$67K
SSI
2271
DELISTED
Stage Stores Inc
SSI
-3,108
Closed -$25K
ALGR
2272
DELISTED
Allegro Merger Corp
ALGR
-250,000
Closed -$2.56M
SPCE.WS
2273
DELISTED
Virgin Galactic Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stoc
SPCE.WS
-133,333
Closed -$447K
CCC.WS
2274
DELISTED
Clarivate Analytics Plc Warrants, each to purchase one Ordinary Share
CCC.WS
-599,999
Closed -$3.75M
HABT
2275
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
-153,975
Closed -$1.6M

Similar funds

Marshall Wace's Q1 2020 Portfolio in Review

As of Q1 2020, Marshall Wace held 2,308 positions worth $10B, down 31% from $14.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marshall Wace withdrew a net $1.63B in Q1 2020, closing 723 positions and reducing 491 holdings. Its most notable exit was eBay, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Marshall Wace opened a new position in Bank of Montreal worth $53.5M.

  • Marshall Wace's largest Q1 2020 buy was Bank of Montreal: 1,072,183 shares worth $53.5M.
  • Marshall Wace added most to Fidelity National Information Services in Q1 2020, an estimated $146M increase.
  • Marshall Wace's biggest Q1 2020 reduction was Boston Scientific, cutting an estimated $173M.
  • Marshall Wace fully exited eBay in Q1 2020, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 18% of its $10B portfolio in Q1 2020.
  • Marshall Wace opened 654 new positions and closed 723 in Q1 2020.
  • Marshall Wace's portfolio value fell 31% quarter-over-quarter to $10B.

Based on Marshall Wace's 13F filing for Q1 2020, filed 15 May 2020.